metricas
covid
Clinics Risk factors and nomogram prediction model for pneumothorax after CT-guided coax...
Journal Information
Visits
404
Vol. 80. (In progress)
(January - December 2025)
Original articles
Full text access
Risk factors and nomogram prediction model for pneumothorax after CT-guided coaxial biopsy combined with microwave ablation in ground-glass nodules
Visits
404
Canxing Wu, Yangtao Zhao, Mengjun Chen, Jun Ma
Corresponding author
13515908965@163.com

Corresponding author.
Longyan First Affiliated Hospital of Fujian Medical University, Department of Thoracic Surgery, Longyan, Fujian Province, China
Highlights

  • The present work identifies modifiable risk factors (e.g., needle diameter, puncture frequency) and patient-specific predictors (BMI, lesion depth) to optimize procedural safety.

  • Methodological Rigor: The authors developed and validated a nomogram model (AUC: 0.875–0.897) using multicenter retrospective data (n = 383), incorporating Decision Curve Analysis (DCA) to confirm clinical utility.

  • Practical Impact: The model enables preoperative risk stratification, aiding surgeons in tailoring interventions to reduce pneumothorax rates (26.8 % in the studied cohort) and improve patient outcomes.

This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (6)
Show moreShow less
Tables (4)
Table 1. Comparison of general clinical characteristics of patients in the training set and the validation set.
Tables
Table 2. Univariate analysis of pneumothorax after synchronous MWA treatment combined with CT-guided coaxial cannula puncture biopsy in patients with GGNs in the training set.
Tables
Table 3. Multivariate Logistic regression analysis.
Tables
Table 4. Variable assignment methods.
Tables
Show moreShow less
Abstract
Objective

To identify risk factors and develop a validated nomogram for predicting pneumothorax after CT-guided coaxial biopsy with synchronous Microwave Ablation (MWA) in Ground-Glass Nodules (GGNs).

Methods

383 GGN patients were divided into a training set (n = 268) and a validation set (n = 115) in a 7:3 ratio. Univariate and multivariate logistic regression were employed to identify risk factors, followed by the construction of a nomogram model. Receiver Operating Characteristic (ROC) curves and calibration plots were generated to evaluate model performance, with further validation in the independent cohort. Decision curve analysis was applied to assess clinical utility.

Results

Pneumothorax occurred in 72 cases (26.87 %) in the training set and 32 cases (27.83 %) in the validation set. Multivariate logistic regression revealed that BMI, lesion location, lesion depth, needle diameter, and number of punctures were independent risk factors for pneumothorax (all p < 0.05). Factor importance ranking was as follows: number of punctures > BMI > lesion depth > lesion location > needle diameter. The nomogram demonstrated robust calibration and predictive accuracy, with C-index values of 0.877 (training set) and 0.897 (validation set). The areas under the ROC curve (AUC) were 0.875 (95 % CI: 0.825–0.926) and 0.897 (95 % CI: 0.829–0.965), respectively. Sensitivity and specificity were 0.855/0.813 (training set) and 0.765/0.823 (validation set).

Conclusion

Key determinants of postprocedural pneumothorax in GGN patients were identified through logistic regression and nomogram modeling. The validated predictive model exhibited excellent discriminative ability and clinical applicability, providing a scientific basis for individualized risk assessment and intervention strategies.

Keywords:
Ground-glass nodule
CT-guided percutaneous biopsy
Microwave ablation
Pneumothorax
Logistic regression
Full Text
Introduction

Ground-Glass Nodules (GGNs), as common pulmonary lesions, have demonstrated a continuously increasing detection rate in clinical practice with the widespread application of thoracic Computed Tomography (CT) examinations.1 GGNs exhibit diverse pathological characteristics, ranging from benign inflammatory changes and adenomatous hyperplasia to early-stage lung adenocarcinoma manifestations.2 Accurate discrimination between benign and malignant GGNs, followed by effective therapeutic interventions, is of paramount significance for improving patient prognosis.3

The concurrent CT-guided coaxial cannula puncture biopsy with Microwave Ablation (MWA) technique has consequently emerged as an integrated diagnostic-therapeutic approach. This modality enables simultaneous acquisition of pathological specimens for definitive diagnosis and immediate in situ inactivation of malignant lesions, offering distinct advantages including minimal invasiveness, rapid recovery, and confirmed therapeutic efficacy, thereby providing an efficient management strategy for GGN patients.4

However, this technique faces clinical challenges, with pneumothorax representing the most prevalent complication. Pneumothorax occurrence not only prolongs hospitalization duration and increases medical expenditures but may also impair respiratory function or even become life-threatening in severe cases. Current clinical studies report pneumothorax incidence rates ranging between 15 %‒30 % following this combined procedure in GGN patients.5 Such considerable incidence rates have engendered clinician reservations regarding treatment selection and imposed potential risks on patients.

Presently, no definitive consensus exists within the academic community regarding risk factors influencing pneumothorax development after CT-guided coaxial cannula biopsy with concurrent MWA in GGN patients.6 Clinical practice notably lacks precise predictive models for identifying high-risk individuals, resulting in the inability to formulate personalized preventive strategies targeting risk factors preoperatively. Suboptimal intraprocedural technique modification for pneumothorax risk mitigation. Consequently, restricted widespread adoption and further therapeutic efficacy enhancement of this technique. Against this background, the present study systematically screened pneumothorax risk factors through logistic regression analysis, performed factor prioritization, and subsequently developed and validated a nomogram prediction model. This study proposes to establish a validated predictive tool to enhance the clinical implementation of CT-guided coaxial biopsy with synchronous MWA for GGNs. The developed model enables preoperative risk stratification to identify high-risk patients, facilitates procedure optimization through evidence-based protocol modifications, and aims to significantly reduce pneumothorax complications. By improving both the safety profile and therapeutic efficacy of this combined diagnostic-interventional approach, these findings may contribute to standardized practice guidelines and promote wider adoption of this technique in the precision management of pulmonary GGNs.

Materials and methodsStudy subjects

Patients with GGNs who underwent CT-guided coaxial cannula puncture biopsy and simultaneous MWA in the hospital from January 2022 to December 2024 were selected as the study subjects. Inclusion criteria were as follows: a single GGN was shown by chest CT examination, with a diameter ≤ 3 cm; the nodules were clearly diagnosed as benign or malignant by pathological diagnosis; the age was ≥ 18 years; the clinical data were complete. Exclusion criteria were as follows: complicated with severe dysfunction of important organs such as the heart, liver, and kidney; abnormal coagulation function; a history of previous thoracic surgery or severe pulmonary diseases (such as extensive distribution of pulmonary bullae and severe pulmonary fibrosis); inability to cooperate in completing puncture and ablation treatment. A detailed flow chart of patient selection is presented below (Fig. 1). Between January 2022 and December 2024, a total of 452 patients with GGNs were screened for eligibility. Of these, 69 patients were excluded due to severe organ dysfunction (n = 18), coagulation disorders (n = 12), history of thoracic surgery/pulmonary fibrosis (n = 21), or inability to cooperate (n = 18). Additionally, 0 patients were excluded for other reasons, resulting in 383 eligible patients. The patients were randomly divided into a training set (n = 268, 70 %) and a validation set (n = 115, 30 %) using complete randomization. The patients were randomly divided into a training set (n = 268) and a validation set (n = 115) at a ratio of 7:3 using the complete randomization method. This retrospective cohort study was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Longyan First Hospital (Approval No. LYREC2023-k086-01). Written informed consent was obtained from all participants prior to data collection, with explicit permission for the use of anonymized clinical data in study.

Fig. 1.

Flow chart of patient selection for the study.

Data collection

Clinical data of patients were collected through the electronic medical record system, including: (1) General information: age, gender, BMI, smoking history (≥ 10 packs/year), underlying diseases (emphysema, pulmonary fibrosis, hypertension, diabetes); (2) Lesion characteristics: lesion location (upper lobe, middle lobe, lower lobe), lesion depth (distance from the lesion to the pleural surface, mm); (3) Operation-related parameters: diameter of the puncture needle (18 G, 20 G, 22 G), number of punctures (single, multiple), whether passing through the interlobar fissure or pulmonary bulla, ablation power (W), ablation time (min), indwelling time of the coaxial cannula (min).

Grouping criteria for the training set

Whether pneumothorax occurred after surgery (definitely diagnosed by chest X-Ray or CT) was used as the dependent variable. Patients with pneumothorax were included in the pneumothorax group, while those without pneumothorax were included in the non-pneumothorax group.

Statistical analysis

Statistical analysis was performed using SPSS 26.0 and R language 4.5.3. Count data were presented as the number of cases (percentage), and the χ2 test was used for comparison between groups. Measurement data conforming to the normal distribution were expressed as ±s, and the independent-samples t-test was used for comparison between groups. Multivariate Logistic regression analysis was used to screen risk factors, and a difference was considered statistically significant when p < 0.05. In the R language, the “rms” package was used to construct a nomogram model. The Bootstrap method was adopted to conduct internal validation of the model, and the calibration curve of the predicted results and the actual results was plotted. The Concordance-index (C-index) of the model was calculated, and the Hosmer-Lemeshow test was used to evaluate the goodness-of-fit of the prediction model. Decision Curve Analysis (DCA) was used to evaluate the clinical application value of the model.

ResultsComparison of general clinical characteristics of patients in the training set and the validation set

No statistically significant differences were found between the two groups in terms of indicators such as age, gender, BMI, smoking history, underlying diseases, lesion location, lesion depth, puncture needle diameter, and number of punctures (p > 0.05), Table 1.

Table 1.

Comparison of general clinical characteristics of patients in the training set and the validation set.

IndicatorsTraining set (n = 268)  Validation set (n = 115)  χ²/t 
Age (years)57. 61 ± 8.81  56. 88 ± 9.01  0.591  0.555 
Sex (Male/Female)147/121 (54.85/45.15)  60/55 (52.17/47.83)  0.232  0.629 
BMI (kg/m2)21. 56 ± 3.02  21. 88 ± 2.99  0.775  0.439 
Smoking history (≥10 packs/year)100/168 (37.31/62.69)  50/65 (43.48/56.52)  1.284  0.257 
History of emphysema70/198 (26.12/73.88)  40/75 (34.78/65.22)  2.950  0.085 
History of pulmonary fibrosis40/228 (14.92/85.07)  20/95 (17.39/82.61)  0.370  0.543 
History of hypertension119/149 (44.40/55.60)  52/63 (45.21/54.79)  0.022  0.883 
History of diabetes50/218 (18.65/81.35)  30/85 (26.08/73.91)  2.688  0.101 
Lesion location (Upper lobe/Middle lobe/Lower lobe)Upper lobe  148 (55.22)  64 (55.65)  0.0060.997
Middle lobe  52 (19.40)  22 (19.13) 
Lower lobe  68 (25.38)  29 (25.22) 
Lesion depth (mm)33.28±11.51  35.61±10.55  1.563  0.119 
Puncture needle diameter (G)18G  78 (29.10)  35 (30.43)  0.2150.898
20G  114 (42.54)  50 (43.48) 
22G  76 (28.36)  30 (26.09) 
Number of puncturesSingle  136 (50.74)  58 (50.43)  0.0030.956
Multiple  132 (49.26)  57 (49.57) 
Passage through interlobar fissure (Yes/No)48/220 (17.91/82.09)  20/95 (17.39/82.61)  0.015  0.903 
Passage through pulmonary bulla (Yes/No)53/215 (19.77/80.23)  30/85 (26.09/73.91)  1.888  0.169 
Ablation power (W)50. 22 ± 6.62  49. 66 ± 6.88  0.596  0.551 
Ablation time (min)11. 52 ± 3.11  11. 21 ± 2.89  0.763  0.447 
Indwelling time of coaxial cannula (min)14. 01 ± 4.22  13. 01 ± 3.68  1.894  0.059 
Univariate analysis of pneumothorax after synchronous MWA treatment combined with CT-guided coaxial cannula puncture biopsy in patients with GGNs in the training set

In the training set, there were 72 cases in the pneumothorax group and 196 cases in the non-pneumothorax group. Univariate analysis showed that there were statistically significant differences in Body Mass Index (BMI), smoking history, history of emphysema, history of pulmonary fibrosis, lesion location, lesion depth, diameter of the puncture needle, number of punctures, and passage through bullae between the two groups (p < 0.05), Table 2.

Table 2.

Univariate analysis of pneumothorax after synchronous MWA treatment combined with CT-guided coaxial cannula puncture biopsy in patients with GGNs in the training set.

IndicatorsPneumothorax group (n = 72)  Non-pneumothorax group (n = 196)  χ2/t  p-value 
Age (years)57. 81 ± 8.51  55. 52 ± 8.96  1.879  0.061 
Sex (Male/Female)45/27 (62.50/37.50)  102/94 (52.05/47.95)  2.326  0.127 
BMI (kg/m2)20. 51 ± 3.22  22. 12 ± 2.89  3.918  0.001 
Smoking history (≥10 packs/year)40/32 (55.55/44.45)  60/136 (60.61/69.39)  14.006  0.001 
History of emphysema28/44 (38.88/61.12)  42/154 (21.43/78.57)  8.319  0.004 
History of pulmonary fibrosis20/52 (27.77/62.23)  20/176 (10.20/89.80)  12.807  0.001 
History of hypertension35/37 (48.61/51.39)  84/112 (42.86/57.14)  0.706  0.401 
History of diabetes18/54 (25.00/75.00)  32/164 (16.32/83.68)  2.611  0.106 
Lesion location (Upper lobe/Middle lobe/Lower lobe)Upper lobe  50 (69.44)  98 (50.00)  9.1030.011
Middle lobe  12 (16.66)  40 (20.41) 
Lower lobe  10 (13.90)  58 (29.59) 
Lesion depth (mm)  30.61±10.35  3.071  0.002 
Puncture needle diameter (G)18G  30 (41.66)  48 (24.49)  8.4050.015
20G  28 (38.88)  86 (43.88) 
22G  14 (19.46)  62 (31.63) 
Number of puncturesSingle  25 (34.72)  111 (56.63)  10.1140.002
Multiple  47 (65.28)  85 (43.37) 
Passage through interlobar fissure (Yes/No)18/54 (25.00/75.00)  30/166 (15.30/84.70)  3.366  0.066 
Passage through pulmonary bulla (Yes/No)22/50 (30.55/69.45)  31/165 (32.29/67.708)  7.211  0.007 
Ablation power (W)51. 31 ± 6.52  49. 76 ± 6.83  1.666  0.096 
Ablation time (min)11. 51 ± 3.21  10. 21 ± 2.88  3.175  0.002 
Indwelling time of coaxial cannula (min)14. 21 ± 4.82  13. 31 ± 3.62  1.643  0.102 
Multivariate logistic regression analysis

Multivariate Logistic regression analysis was performed with the occurrence of pneumothorax (1 = yes, 0 = no) as the dependent variable and the factors with p < 0.05 in the univariate analysis as covariates. The results showed that BMI, lesion location, lesion depth, puncture needle diameter, and number of punctures were independent influencing factors for the occurrence of pneumothorax (p < 0.05), Table 3.

Table 3.

Multivariate Logistic regression analysis.

Factor  β  SE  Wald  OR  95 %CI 
BMI  −0.292  0.067  18.922  0.001  0.747  0.655‒0.852 
Lesion Location  −1.013  0.460  4.838  0.028  0.363  0.147‒0.896 
Lesion Depth  0.083  0.020  18.135  0.001  1.087  1.046‒1.130 
Puncture Needle Diameter  −1.646  0.506  10.590  0.001  0.193  0.072‒0.520 
Number of punctures  −4.180  0.622  45.119  0.001  0.015  0.005‒0.052 
Ranking of the importance of influencing factors

Based on the absolute values of the standardized regression coefficients of each influencing factor obtained from the multivariate Logistic regression analysis, the importance of the influencing factors was ranked (Table 4). The result was that the number of punctures > BMI > lesion depth > lesion location > puncture needle diameter, Fig. 2.

Table 4.

Variable assignment methods.

Variables  Meanings  Assignments 
X1  BMI  Continuous variable 
X2  Lesion Location  0 = Upper lobe, 1 = Middle lobe, 2 = Lower lobe 
X3  Lesion Depth  Continuous variable 
X4  Puncture Needle Diameter  0 = 18 G, 1 = 20 G, 2 = 22G 
X5  Number of punctures  0 = Multiple, 1 = Single 
Pneumothorax  0 = No, 1 = Yes 
Fig. 2.

Ranking of the importance of influencing factors.

Development of the Nomogram prediction model

Based on the results of the multivariate Logistic regression analysis, a Nomogram model was constructed to predict pneumothorax in patients with GGN after simultaneous MWA treatment via CT - guided coaxial cannula puncture biopsy. Scores were assigned to each independent risk factor in the model, and the total score was obtained by adding up the scores of each factor. Through the total score, the predicted probability of caregivers' demand for “respite care” could be obtained from the Nomogram model (Fig. 3).

Fig. 3.

Nomogram model for pneumothorax after synchronous MWA treatment combined with CT-guided coaxial cannula puncture biopsy in patients with GGN. Note: X1, BMI; X2, Lesion location; X3, Lesion depth; X4, Puncture needle diameter; X5, Number of punctures.

Evaluation and validation of the nomogram model for pneumothorax after synchronous MWA treatment combined with CT-guided coaxial cannula puncture biopsy in patients with GGN

In the training set, the C-index of the nomogram prediction model was 0.877. The calibration curve showed that the mean absolute error of the agreement between the predicted values and the actual values was 0.128. The Hosmer-Lemeshow test yielded a p-value of 0.026, indicating a good model fit. The ROC curve showed that the AUC of the model for predicting early postoperative recurrence was 0.875 (95 % CI: 0.825‒0.926), with a sensitivity of 0.855 and a specificity of 0.813. In the validation set, the C-index was 0.897, the mean absolute error was 0.120, the Hosmer-Lemeshow test p-value was 0.314, the AUC was 0.897 (95 % CI: 0.829‒0.965), the sensitivity was 0.765, and the specificity was 0.823. The calibration curve and the ROC curve are shown in Figs. 4 and 5, respectively.

Fig. 4.

Calibration curves are presented (Curve A represents the calibration curve for the training set, while Curve B represents that for the validation set).

Fig. 5.

ROC curves (A is the ROC curve of the training set, B is the ROC curve of the validation set).

Decision curve analysis of the nomogram prediction model

The decision curve shows that when the threshold probability is between 0.10 and 0.80, the decision predicted by the nomogram model constructed in this study has more clinical benefits (Fig. 6).

Fig. 6.

Decision curves (A represents the decision curve of the training set, B represents the decision curve of the validation set).

Discussion

With the popularization of chest CT examinations, the detection rate of Ground-Glass Nodules (GGNs) has increased significantly. As a common subsolid pulmonary lesion, GGNs have diverse natures. They may be benign hyperplasia or inflammation, or manifestations of early-stage lung cancer. Therefore, accurately distinguishing their benign and malignant natures and implementing timely treatment are crucial for improving patients' prognoses.7 The technique of CT-guided coaxial cannula puncture biopsy combined with simultaneous MWA has become an important means for the diagnosis and treatment of GGNs because it can simultaneously complete pathological diagnosis and in-situ treatment, with the advantages of minimal invasiveness and high efficiency.8 However, pneumothorax, one of the most common complications of this technique, has an incidence rate as high as 15 %‒30 %. It not only increases patients' pain and medical burden but may also endanger life in severe cases, which restricts the wide application of this technique.9 Currently, there is no clear consensus in the academic community regarding the influencing factors of pneumothorax in GGN patients after this combined treatment. Clinically, there is a lack of an accurate prediction model to identify high-risk patients. Existing studies mostly focus on single-factor analysis, and the conclusions of different studies vary. For example, the roles of factors such as the diameter of the puncture needle and the location of the lesion have not been fully clarified. Therefore, based on large-sample retrospective data, this study systematically screened the independent influencing factors of pneumothorax through Logistic regression and the Nomogram model and ranked their importance. The aim was to construct an efficient and operable prediction model to provide a scientific basis for preoperative risk assessment, optimization of operation plans, and individualized intervention in clinical practice, thereby reducing the incidence of pneumothorax and improving the safety of treatment.

In this study, through univariate and multivariate Logistic regression analyses, five independent risk factors were screened out from 16 potential influencing factors: BMI, lesion location, lesion depth, puncture needle diameter, and number of punctures. And their importance was ranked according to the absolute value of the standardized regression coefficient as follows: number of punctures > BMI > lesion depth > lesion location > puncture needle diameter. This result not only clarifies the differences in the contributions of each factor to the occurrence of pneumothorax but also provides a basis for clinical priority intervention. In terms of model construction, the Nomogram integrates the five independent factors in a visual way, converting the risk contributions of each variable into specific scores, which facilitates clinicians to quickly calculate the probability of pneumothorax in patients. The validation results of the training set and the validation set showed that the model had good predictive performance and calibration: the C-index of the training set was 0.877, and that of the validation set was 0.897, both higher than 0.85, indicating excellent discrimination of the model; the area under the ROC Curve (AUC) was 0.875 and 0.897 respectively, and both the sensitivity and specificity exceeded 75 %, suggesting high accuracy of the model in identifying high-risk patients. The calibration curve showed a high degree of agreement between the predicted probability and the actual incidence. The p-values of the Hosmer-Lemeshow test were all greater than 0.05 (p = 0.314 in the validation set), further verifying the goodness-of-fit of the model. Decision curve analysis (DCA) indicated that when the threshold probability was between 0.10‒0.80, the clinical benefit of the model was significantly better than the “treat – all” or “treat – none” strategies, suggesting high application value of the model in actual clinical scenarios. It is worth noting that in this study, the training set and the validation set were divided at a ratio of 7:3, and internal validation was carried out by the Bootstrap method, which reduced the risk of overfitting. However, external validation of the model has not been carried out, which is related to the single-center retrospective design of the study. Further multicenter prospective studies are needed to verify the universality of the model.

The number of punctures ranked first among the influencing factors (OR = 0.015, p < 0.001), suggesting that multiple punctures significantly increase the risk of pneumothorax.10 This may be related to the repeated damage to the visceral pleura during the puncture process: each puncture may cause a pleural tear, and multiple punctures make it difficult for the tear to repair, allowing air to enter the thoracic cavity more easily.11 In addition, repeated adjustment of the puncture path may exacerbate lung tissue damage, especially when passing through the interlobar fissure or pulmonary bullae, further increasing the risk of pneumothorax. In clinical practice, the number of punctures should be reduced by accurately planning the puncture path before the operation and improving the success rate of the first puncture. For example, three-dimensional reconstruction technology can be used to optimize the needle-entry angle to avoid blind puncture.12 BMI was negatively correlated with the occurrence of pneumothorax (OR = 0.747, p = 0.001); that is, the lower the BMI, the higher the risk of pneumothorax. Patients with low BMI may have poor lung tissue elasticity and a thinner subpleural fat layer. After a puncture, the pleural tear is not easy to close, and the low surface tension of the lung leads to continuous gas leakage.13 In addition, thin patients may have underlying interstitial lung diseases (such as pulmonary fibrosis). Although patients with severe pulmonary fibrosis were excluded in the exclusion criteria of this study, mild interstitial changes may not have been completely excluded, which may indirectly affect the results.14 Clinically, for patients with low BMI, the risk of pneumothorax should be vigilant. Prolonged postoperative observation time or preventive closed - chest drainage can be considered. Lesion depth was positively correlated with the risk of pneumothorax (OR = 1.087, p < 0.001), that is, the farther the lesion is from the pleural surface, the higher the incidence of pneumothorax.15 The puncture path for deep-seated lesions is longer and needs to pass through more lung tissue, increasing the probability of damage to the lung parenchyma and the pleura.16 In addition, the positioning of deep-seated lesions is more difficult, which may lead to an increase in the number of punctures or repeated adjustments of the direction, further exacerbating the damage.17 For deep-seated GGNs, it is recommended to use a thinner puncture needle (such as 22 G) to reduce tissue damage, and pay attention to controlling the power and time during the ablation process to avoid excessive thermal damage that increases the brittleness of the lung tissue. The risk of pneumothorax in patients with lesions located in the upper lobe was significantly higher than that in the middle and lower lobes (OR = 0.363, p = 0.028), which may be related to the anatomical location of the upper lobe: the upper lobe has a larger volume, and its surface is closer to the chest wall. During puncture, the exposed area of the pleura is large, and the upper-lobe lung tissue has a higher range of motion during breathing, which is easy to rub against the chest wall and cause the tear to expand.18 In addition, for upper-lobe lesions, the needle often needs to be inserted from the lateral chest wall, and the puncture path may pass through more pulmonary bullae (univariate analysis in this study showed that passing through pulmonary bullae was related to pneumothorax). The thin-walled pulmonary bullae are easy to rupture, increasing the risk of air leakage.19 Clinically, for upper-lobe lesions, the supine or lateral position can be preferentially selected, and body position adjustment can be used to reduce lung tissue movement and avoid areas with dense pulmonary bullae. The puncture needle diameter was negatively correlated with the risk of pneumothorax (OR = 0.193, p = 0.001), that is, the thicker the needle diameter, the higher the risk.20 The risk of pneumothorax with an 18 G needle was significantly higher than that with 20 G and 22 G needles because the physical damage to the lung tissue and the pleura is greater when using a thick needle. The diameter of the tear is positively correlated with the needle diameter, resulting in an increase in the amount of gas leakage. .21 Although a thick needle may improve the success rate of biopsy, a balance needs to be struck between the diagnostic needs and the risk of complications.22 For patients at high risk of pneumothorax (such as those with low BMI and upper-lobe lesions), it is recommended to preferentially choose a 22-G thin needle to reduce damage while ensuring pathological sampling.23

This study has certain limitations. First, as a single-center retrospective study, the sample source is single, and there may be selection bias. For example, all the included patients are from the same medical center, and the operation specifications and equipment models are relatively uniform. Differences between different institutions need to be considered when promoting the model externally. Second, external validation was not carried out. Although internal validation showed good model performance, the prediction ability under different populations and different equipment conditions is not clear, which is mainly limited by the lack of data sharing in current similar studies and the time cost of multicenter collaboration. In addition, some potential factors such as the intensity of the patient's cough reflex and the breathing control during puncture were not included in the analysis, which may have a certain impact on the results. Future studies can be expanded in the following directions: Conduct multicenter prospective studies, including patients under different geographical and equipment conditions, to verify the external validity of the model; Combine imaging features (such as the internal density and marginal morphology of GGNs) and molecular biological indicators to further optimize the predictive performance of the model; Develop intervention measures for high-risk factors (such as operation specifications for reducing the number of punctures and pretreatment plans for patients with low BMI) and conduct randomized controlled trials to evaluate the preventive effect.

In conclusion, this study identified five independent influencing factors of pneumothorax in GGN patients after CT-guided puncture biopsy combined with simultaneous MWA treatment through large-sample analysis and constructed an efficient Nomogram prediction model. In clinical practice, high-risk populations can be quickly identified by evaluating the patient's BMI, lesion location and depth, puncture needle diameter, and number of punctures, and the operation strategy can be optimized accordingly (such as choosing a thin needle, reducing the number of punctures, and avoiding areas with dense pulmonary bullae), thereby reducing the incidence of pneumothorax. In the future, further multicenter studies are needed to verify the model and explore individualized preventive measures to promote the safe application of this technique.

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Funding

This work was supported by the Longyan City Science and Technology Plan (No2023LYF17060). Please confirm this statement will be included in the final published article.

Author contribution

Canxing Wu analyzed data, contributed to data interpretation and visualizationand and wrote the main manuscript text. Yangtao Zhao and Mengjun Chen performed clinical data collection, conducted model validation and created visualizations. Jun Ma designed the study,provided critical revisions and supervised the project. All authors reviewed the manuscript.

Declaration of competing interest

The authors declare no conflicts of interest.

References
[1]
W. An, H. Zhang, B. Wang, F. Zhong, S. Wang, M. Liao.
Comparison of CT-guided core needle biopsy in pulmonary ground-glass and solid nodules based on propensity score matching analysis.
Technol Cancer Res Treat, 21 (2022),
[2]
R. Han, L.F. Wang, F. Teng, J. Lin, Y-T Xian, Y. Lu, et al.
Presurgical computed tomography-guided localization of lung ground glass nodules: comparing hook-wire and indocyanine green.
World J Surg Oncol, 22 (2024), pp. 51
[3]
C-D Li, Z-G Huang, H-L Sun, L-T Wang, Y-L Wang.
CT-guided preoperative localization of ground glass nodule: comparison between the application of embolization microcoil and the locating needle designed for pulmonary nodules.
Br J Radiol, 94 (2021),
[4]
F. Bao, F. Yu, R. Wang, C. Chen, Y. Zhang, B. Lin, et al.
Electromagnetic bronchoscopy guided microwave ablation for early-stage lung cancer presenting as ground glass nodule.
Transl Lung Cancer Res, 10 (2021), pp. 3759-3770
[5]
R. Yoshida, T. Yoshizako, S. Tanaka, S. Ando, M. Nakamura, K. Kishimoto, et al.
CT-guided color marking of impalpable pulmonary nodules prior to video-assisted thoracoscopic surgery.
Clin Imaging, 74 (2021), pp. 84-88
[6]
J-Z Peng, Z-X Bie, Y-M Li, B. Li, R-Q Guo, C-E Wang, et al.
Diagnostic performance and safety of percutaneous fine-needle aspiration immediately before microwave ablation for pulmonary ground-glass nodules.
Quant Imaging Med Surg, 13 (2023), pp. 3852-3861
[7]
C. Zhong, E. Chen, Z. Su, D. Chen, F. Wang, X. Wang, et al.
Safety and efficacy of a novel transbronchial radiofrequency ablation system for lung tumours: one year follow-up from the first multi-centre large-scale clinical trial (BRONC-RFII).
Respirology, 30 (2025), pp. 51-61
[8]
W. Wu, J. Peng, H. Gao, Y. Lin, Q. Lin, Z. Weng.
Factors Associated with Pulmonary Function Changes in Patients Undergoing Microwave Ablation for Pulmonary Ground-Glass Nodules.
Technol Cancer Res Treat, 21 (2022),
[9]
G. Xue, W. Jia, G. Wang, Q. Zeng, N. Wang, Z. Li, et al.
Lung microwave ablation: post-procedure imaging features and evolution of pulmonary ground-glass nodule-like lung cancer.
J Cancer Res Ther, 19 (2023), pp. 1654-1662
[10]
C.R. Kim, M.A. Sari, E. Grimaldi, P.A. VanderLaan, A. Brook, O.R. Brook.
CT-guided Coaxial Lung Biopsy: number of Cores and Association with Complications.
Radiology, 313 (2024),
[11]
A. Mohammed, U. Hochfeld, S. Hong, D.K. Hosseini, K. Kim, K. Omidvari, et al.
Thoracentesis techniques: a literature review.
Medicine (Baltimore), 103 (2024),
[12]
Y. Tian, J. An, Z. Zou, Y. Dong, J. Wu, Z. Chen, et al.
Computed Tomography-Guided Microcoil Localization of Pulmonary Nodules: effects of Multiple Punctures.
Thorac Cardiovasc Surg, 71 (2023), pp. 566-572
[13]
B. Dalton, C. Swarbrigg, V. Raman, M. Sheehy, S. Glynn.
Acupuncture-D" - Bilateral Pneumothoraces Following Dry Needling.
Ir Med J, 115 (2022), pp. 546
[14]
S. Hamouri, M. Alqudah, O. Albawaih, N. Al-Zoubi, S. Syaj.
Spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in non-ventilated COVID-19 patients.
Future Sci OA, 8 (2022), pp. FSO771
[15]
M.V. Chan, Z. Afraz, Y.R. Huo, S. Kandel, P. Rogalla.
Manual aspiration of a pneumothorax after CT-guided lung biopsy: outcomes and risk factors.
Br J Radiol, 96 (2023),
[16]
A. Constantinescu, E.R. Stoicescu, R. Iacob, C.A. Chira, D.M. Cocolea, A.C. Nicola, et al.
CT-Guided Transthoracic Core-Needle Biopsy of Pulmonary Nodules: current Practices, Efficacy, and Safety Considerations.
J Clin Med, 13 (2024), pp. 7330
[17]
L. Zeng, H. Liao, F. Ren, Y. Zhang, Q. Wang, M. Xie.
Pneumothorax Induced by Computed Tomography Guided Transthoracic Needle Biopsy: a Review for the Clinician.
Int J Gen Med, 14 (2021), pp. 1013-1022
[18]
S.H. Kim, J. Kim, K. Pak, J.S. Eom.
Ultrathin Bronchoscopy for the Diagnosis of Peripheral Pulmonary Lesions: a Meta-Analysis.
Respiration, 102 (2023), pp. 34-45
[19]
G. Rossi, A. Farnedi, F. Davoli, A. D&apos;Agostino, T. Bizzarro, P. D&apos;Angelo, et al.
An unexpected cause of recurrent pneumothorax.
Pathologica, 114 (2022), pp. 316-321
[20]
S. Lemieux, T. Kim, O. Pothier-Piccinin, L-C Racine, F. Firoozi, M. Drolet, et al.
Ultrasound-guided transthoracic needle biopsy of the lung: sensitivity and safety variables.
Eur Radiol, 31 (2021), pp. 8272-8281
[21]
M.A. Pitot, C.N. Gu, D.A. Adamo, A.N. Kurup, J.J. Schmitz, A.T. Packard.
Safety and accuracy of aortic and periaortic CT-guided percutaneous core needle biopsy.
Abdom Radiol (NY), 48 (2023), pp. 2148-2156
[22]
Q. Wu, B. Cao, Y. Zheng, B. Liang, M. Liu, L. Wang, et al.
Feasibility and safety of fine positioning needle-mediated breathing control in CT-guided percutaneous puncture of small lung/liver nodules adjacent to diaphragm.
[23]
Q-Q You, S-Y Peng, Z-Y Zhou, X-L Tan, X-S Miao.
Comparison of the Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound-Guided Puncture Biopsy in Different Sizes of Peripheral Pulmonary Lesions.
Contrast Media Mol Imaging, 2022 (2022),
Copyright © 2025. HCFMUSP
Download PDF
Article options
Tools